Ascentage Pharma Group International (HKG:6855) has filed for a proposed initial public offering with the US Securities Exchange Commission on Friday, according to a Sunday filing with the Hong Kong Stock Exchange.
The drug company plans to list the American depositary shares (ADSs) under the symbol AAPG.
The number of ADSs to be offered and the offering's price range has yet to be decided.
The offering's closing is subject to the approvals of regulatory authorities and bourses in Hong Kong and the US, among other conditions.
JP Morgan Securities and Citigroup Global Markets act as joint book-running managers for the offering.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。